Metabolic Reprogramming in Cancer Stem Cells

Area of Science:

• Cancer Biology
• Metabolic Pathways
• Tumor Microenvironment

Background:

• Cancer stem cells (CSCs) possess self-renewal and differentiation capabilities, contributing to therapy resistance and relapse.
• CSCs exhibit metabolic flexibility, adapting energy production (glycolysis, oxidative phosphorylation) and biosynthesis (lipids, amino acids) to survive stress and low oxygen.
• The tumor microenvironment (TME) influences CSC metabolism through cellular crosstalk and metabolic interplay, such as the reverse Warburg effect.

Purpose of the Study:

• To explore the metabolic adaptability of cancer stem cells (CSCs).
• To understand how metabolic reprogramming contributes to CSC survival, tumor progression, and therapy resistance.
• To identify metabolic vulnerabilities of CSCs for novel therapeutic strategies.

Main Methods:

• Analysis of metabolic pathways utilized by CSCs, including glycolysis, oxidative phosphorylation (OXPHOS), and fatty acid oxidation.
• Investigation of the role of amino acid metabolism (glutamine, serine, glycine) in CSC survival and biosynthesis.
• Examination of the influence of the tumor microenvironment (TME) on CSC metabolic reprogramming.

Main Results:

• CSCs dynamically switch between glycolysis and OXPHOS depending on the biological context.
• Lipid and amino acid metabolism are crucial for CSC energy production, biosynthesis, redox homeostasis, and epigenetic regulation.
• Metabolic interplay within the TME, like the reverse Warburg effect, supports CSC survival and therapy resistance.

Conclusions:

• Metabolic reprogramming is fundamental to CSC survival, therapy resistance, and tumor progression.
• Targeting CSC metabolism using glycolytic, mitochondrial, lipid, or amino acid inhibitors can enhance tumor sensitivity to conventional therapies.
• Combinatorial therapies targeting CSC metabolism show promise for achieving durable and effective cancer treatment outcomes.